Biotechnology is a priority of Vyatka Province
The development of the biotechnological industry in the Kirov region has been declared one of the priorities.
27.04.2012The development of the biotechnological industry in the Kirov region has been declared one of the priorities.
27.04.2012Siberian Federal University will open an enterprise for the production of biodegradable polymers for medical needs at the end of 2012.
26.04.2012Investments of business angels in venture (risky and young) business projects in Russia are 10 times less than in Europe and 70 times less than in the USA.
25.04.2012The construction of an innovative economy in Russia should be as open as possible to the outside world, otherwise it will be uncompetitive, Anatoly Chubais believes.
23.04.2012On April 27-28, 2012, St. Petersburg State University will host an international scientific conference dedicated to the opening of the Center for Genomic Bioinformatics.
20.04.2012Notes of a technology startup about the venture industry – Russian and Western.
19.04.2012According to the latest report of marketers, by 2016 the market volume of equipment for studying the genome will reach 9 billion US dollars.
18.04.2012Currently, more than 140 startups in the field of systems biology, bioinformatics, biotechnology and in various fields of medicine are registered in the Skolkovo biomedical cluster.
05.04.2012Venture funds intend to develop a strategic partnership for investment activities in the biopharmaceutical and medical industries of Russia and Germany.
05.04.2012At the annual conference on the problems of economic and social development, E. Nabiullina proposed to get off the raw material needle and engage in "non-traditional exports".
03.04.2012The governments of European countries face an important task – to use the results of R&D in the creation of new biotech companies, goods and jobs, emphasized in the report prepared by Ernst & Young and EuropaBio.
29.03.2012The Russian stock market has again fallen below 1600 points on the MICEX index, losing almost all the growth observed a week earlier. Meanwhile, domestic pharmaceutical companies traded noticeably better than the market.
26.03.2012Justifying the high cost of medicines with large research costs has always been a ploy on the part of the pharmaceutical industry.
19.03.2012Economically, Rusnano's actions are logical. But, given the importance of projects, for example, on the diagnosis and treatment of cancer, Rusnano could soften the strict requirements for contractors, experts say.
15.03.2012Relying only on Russian developments, our nanoindustry will not reach the planned production volume by 2015. We have to take all the best that is being created in the West and invest in Russian science and education.
14.03.2012There is no human lactoferrin as a marketable product on the world market. The production of the drug "Neolactoferrin" from the milk of transgenic goats will allow Transgenpharm to occupy a worthy niche in the global biotechnology market.
07.03.2012The names of ten winners of the competition of young scientists specializing in the field of molecular and cellular biology have been announced.
07.03.2012Rusnano and the American venture fund Domain Associates are investing $760 million in the development and production of innovative medicines.
07.03.2012The management of several St. Petersburg biomedical companies that have become participants of the Skolkovo Innovation Center has expressed rather ambitious plans. Will they come to life?
29.02.2012Two American biotech companies are starting work in Russia, where they were attracted by a large investor, an emerging market and scientific potential. If successful, the example can be contagious.
28.02.2012You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.